 Senseonics NYSEAMERICAN: SENS stock jumped by over 50 after it announced its Eversense implantable glucose monitor was approved for coverage by Elevance Health NYSE: ELV , formerly known as Anthem. Senseonics had revenue of just 2.5 million in the first quarter. 